Showing results (701-710 of 753) with videos related to

Sort By:
Pageof 76
European Journal of Pharmacology|December 21, 2020
Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6/IL-6R/STAT3 signalingPengcheng Luo, Yina Wang, Chongqiang Zhao, et al.
RSC Medicinal Chemistry|March 22, 2024
Molecular editing of NSC-666719 enabling discovery of benzodithiazinedioxide-guanidines as anticancer agentsVajja Krishna Rao, Subarno Paul, Mitchell Gulkis, et al.
Journal of Neuroinflammation|September 16, 2022
Investigation and modulation of interleukin-6 following subarachnoid hemorrhage: targeting inflammatory activation for cerebral vasospasmBrandon Lucke-Wold, William Dodd, Kartik Motwani, et al.
Journal of Extracellular Vesicles|July 19, 2017
Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic deliveryDhruvitkumar S Sutaria, Jinmai Jiang, Ola A Elgamal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2023
Oral IRAK-4 Inhibitor CA-4948 Is Blood-Brain Barrier Penetrant and Has Single-Agent Activity against CNS Lymphoma and Melanoma Brain MetastasesChristina A Von Roemeling, Bently P Doonan, Kelena Klippel, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|May 17, 2024
Targeting macrophagic RasGRP1 with catechin hydrate ameliorates sepsis-induced multiorgan dysfunctionZhixi Li, Yongjing Yu, Yue Bu, et al.
Journal of Medicinal Chemistry|January 9, 2020
Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological ActivityVerrill M Norwood, Ariana C Brice-Tutt, Shainnel O Eans, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 2010
Negative allosteric modulators that target human alpha4beta2 neuronal nicotinic receptorsBrandon J Henderson, Ryan E Pavlovicz, Jerad D Allen, et al.
Pageof 76